Cosette Pharmaceuticals chooses Indegene’s MME to assess market for 8 new cardiovascular therapies

Name: Cosette Pharmaceuticals chooses Indegene’s MME to assess market for 8 new cardiovascular therapies
Uploaded: Indegene Archive
Description: Cosette Pharmaceuticals chooses Indegene’s MME to assess market for 8 new cardiovascular therapies. Apurv Saraf, President & CEO shares insights in this video

Jun 2022 · Market Access

Cosette Pharmaceuticals chooses Indegene’s MME to assess market for 8 new cardiovascular therapies. Apurv Saraf, President & CEO shares insights in this video

Explore additional video categories

Analytics
Biotech
Clinical
Commercial
Corporate

Cosette Pharmaceuticals chooses Indegene’s MME to assess market for 8 new cardiovascular therapies

About this video